BidaskClub upgraded shares of Agilent Technologies, Inc. (NYSE:A) from a buy rating to a strong-buy rating in a report released on Sunday morning.
A number of other equities research analysts have also weighed in on A. Barclays PLC reissued a buy rating and set a $67.00 target price on shares of Agilent Technologies in a report on Wednesday, July 19th. Wells Fargo & Company raised shares of Agilent Technologies from a market perform rating to an outperform rating and upped their price objective for the company from $42.92 to $60.73 in a research note on Wednesday, July 12th. Robert W. Baird upped their price objective on shares of Agilent Technologies from $57.00 to $62.00 and gave the company an outperform rating in a research note on Wednesday, May 24th. Cowen and Company upped their price objective on shares of Agilent Technologies from $53.00 to $62.00 and gave the company a market perform rating in a research note on Tuesday, May 23rd. Finally, Zacks Investment Research raised shares of Agilent Technologies from a hold rating to a buy rating and set a $63.00 price objective on the stock in a research note on Tuesday, May 16th. Two research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $60.12.
Agilent Technologies (NYSE A) opened at 59.68 on Friday. The company has a market capitalization of $19.18 billion, a PE ratio of 33.55 and a beta of 1.30. The firm has a 50-day moving average of $60.08 and a 200-day moving average of $55.15. Agilent Technologies has a 52 week low of $42.92 and a 52 week high of $61.84.
Agilent Technologies (NYSE:A) last posted its earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.48 by $0.10. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The firm had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the firm posted $0.44 EPS. The company’s revenue for the quarter was up 8.1% compared to the same quarter last year. Equities analysts expect that Agilent Technologies will post $2.23 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Agilent Technologies, Inc. (NYSE:A) Rating Increased to Strong-Buy at BidaskClub” was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://sportsperspectives.com/2017/08/10/agilent-technologies-inc-nysea-rating-increased-to-strong-buy-at-bidaskclub.html.
The business also recently announced a quarterly dividend, which was paid on Wednesday, July 26th. Investors of record on Monday, July 3rd were paid a dividend of $0.132 per share. This represents a $0.53 annualized dividend and a yield of 0.88%. The ex-dividend date of this dividend was Thursday, June 29th. Agilent Technologies’s dividend payout ratio is presently 29.78%.
In related news, CEO Michael R. Mcmullen sold 50,000 shares of the stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $59.86, for a total transaction of $2,993,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director James Cullen sold 15,482 shares of the stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $59.04, for a total transaction of $914,057.28. The disclosure for this sale can be found here. Over the last three months, insiders have sold 112,608 shares of company stock worth $6,737,509.
A number of hedge funds and other institutional investors have recently modified their holdings of A. Cribstone Capital Management LLC increased its position in Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock valued at $125,000 after buying an additional 54 shares during the last quarter. Parallel Advisors LLC increased its position in Agilent Technologies by 5.3% in the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after buying an additional 131 shares during the last quarter. Trust Co. of Vermont increased its position in Agilent Technologies by 8.1% in the first quarter. Trust Co. of Vermont now owns 2,743 shares of the medical research company’s stock valued at $145,000 after buying an additional 205 shares during the last quarter. CENTRAL TRUST Co increased its position in Agilent Technologies by 15.3% in the first quarter. CENTRAL TRUST Co now owns 2,994 shares of the medical research company’s stock valued at $158,000 after buying an additional 398 shares during the last quarter. Finally, Fiduciary Trust Co. acquired a new position in Agilent Technologies during the second quarter valued at $186,000.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.